Learn More
Medchemexpress LLC Chi-KAT8i5 | 2839860-29-4 | 98.0% | 10 MG

Supplier: Medchemexpress LLC HY16842810MG
CHI-KAT8i5 is a selective, orally active inhibitor of KAT8 (lysine acetyltransferase 8) designed for oncology research. It shows measurable binding to KAT8, inhibits proliferation of esophageal cancer cell lines in vitro, induces dose-dependent apoptosis, and has demonstrated tumor growth suppression in xenograft models.
- Selective KAT8 inhibition with a measured KD of 19.72 μM.
- Cellular antiproliferative activity (IC50 2-3 μM) in esophageal cancer cell lines.
- Induces dose-dependent apoptosis in treated cells.
- Reduces H4K16ac and c-Myc levels in cellular assays.
- Demonstrated oral activity and tumor growth suppression in vivo.
- High DMSO solubility (100 mg/mL) and defined storage recommendations.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.